# Clinical Study of Chidamide Combined With Fulvestrant in the Treatment of Hormone Receptor-positive Advanced Breast Cancer

> **NCT05047848** · NA · UNKNOWN · sponsor: **Liaoning Cancer Hospital & Institute** · enrollment: 82 (estimated)

## Conditions studied

- Advanced Breast Cancer

## Interventions

- **DRUG:** Chidamide
- **DRUG:** Fulvestrant

## Key facts

- **NCT ID:** NCT05047848
- **Lead sponsor:** Liaoning Cancer Hospital & Institute
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-08-18
- **Primary completion:** 2022-06-18
- **Final completion:** 2023-09-18
- **Target enrollment:** 82 (ESTIMATED)
- **Last updated:** 2021-09-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05047848

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05047848, "Clinical Study of Chidamide Combined With Fulvestrant in the Treatment of Hormone Receptor-positive Advanced Breast Cancer". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT05047848. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*